Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, November 20, 2020
[ Fri, Nov 20th 2020
] - WOPRAI
[ Fri, Nov 20th 2020
] - WOPRAI
Thu, November 19, 2020
[ Thu, Nov 19th 2020
] - WOPRAI
[ Thu, Nov 19th 2020
] - WOPRAI
[ Thu, Nov 19th 2020
] - WOPRAI
[ Thu, Nov 19th 2020
] - WOPRAI
[ Thu, Nov 19th 2020
] - WOPRAI
[ Thu, Nov 19th 2020
] - WOPRAI
[ Thu, Nov 19th 2020
] - WOPRAI
[ Thu, Nov 19th 2020
] - WOPRAI
[ Thu, Nov 19th 2020
] - WOPRAI
[ Thu, Nov 19th 2020
] - WOPRAI
[ Thu, Nov 19th 2020
] - WOPRAI
[ Thu, Nov 19th 2020
] - WOPRAI
[ Thu, Nov 19th 2020
] - WOPRAI
[ Thu, Nov 19th 2020
] - WOPRAI
[ Thu, Nov 19th 2020
] - WOPRAI
[ Thu, Nov 19th 2020
] - WOPRAI
[ Thu, Nov 19th 2020
] - WOPRAI
[ Thu, Nov 19th 2020
] - WOPRAI
[ Thu, Nov 19th 2020
] - WOPRAI
[ Thu, Nov 19th 2020
] - WOPRAI
[ Thu, Nov 19th 2020
] - WOPRAI
[ Thu, Nov 19th 2020
] - WOPRAI
[ Thu, Nov 19th 2020
] - WOPRAI
[ Thu, Nov 19th 2020
] - WOPRAI
[ Thu, Nov 19th 2020
] - WOPRAI
[ Thu, Nov 19th 2020
] - WOPRAI
[ Thu, Nov 19th 2020
] - WOPRAI
[ Thu, Nov 19th 2020
] - WOPRAI
Shawn Egan Initiated (ARWR) at Strong Buy and Held Target at $90 on, Nov 19th, 2020
Shawn Egan of Citigroup, Initiated "Arrowhead Pharmaceuticals, Inc." (ARWR) at Strong Buy and Held Target at $90 on, Nov 19th, 2020.
Shawn has made no other calls on ARWR in the last 4 months.
There is 1 other peer that has a rating on ARWR. Out of the 1 peers that are also analyzing ARWR, all agrees with Shawn's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Mani Foroohar of "SVB Leerink" Maintained at Hold with Increased Target to $31 on, Thursday, September 17th, 2020
